Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers
Cécile Le Page, Setor Amuzu, Kurosh Rahimi, Walter H. Gotlieb, Jiannis Ragoussis, Patricia N. Tonin
Topics & Concepts
BiologyGenome instabilityHomologous recombinationDNA repairCancer researchDNA damageOvarian carcinomaSerous fluidOlaparibChemotherapyMutationGermline mutationRAD51BRCA2 ProteinOvarian cancerGenePoly ADP ribose polymerasePolymeraseGeneticsDNACancerBiochemistryPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer